Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effectiveness of speech and language therapy (SLT) interventions on speech and voice problems in people with Parkinson’s disease. We will investigate whether:. SLT is more effective than no SLT; SLT is more effective than placebo or attention control interventions; one SLT intervention is more effective than another SLT intervention (including standard care).
Original language | English |
---|---|
Article number | CD015009 |
Number of pages | 19 |
Journal | Cochrane Database of Systematic Reviews |
Volume | 2022 |
Issue number | 6 |
DOIs | |
Publication status | Published - 6 Jun 2022 |
Bibliographical note
Funding Information:The following people conducted the editorial process for this article. Sign-off Editor (final editorial decision): Robert J Boyle, Cochrane Network Editor. Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Anne-Marie Stephani, Central Editorial Service. Editorial Assistant (conducted editorial policy checks and supported editorial team): Leticia Rodrigues, Central Editorial Service. Copy Editor (copy-editing and production): Jessica Sharp. Sign-off Editor (final editorial decision): Robert J Boyle, Cochrane Network Editor. Managing Editor (selected peer reviewers, collated peer-reviewer comments, provided editorial guidance to authors, edited the article): Anne-Marie Stephani, Central Editorial Service. Editorial Assistant (conducted editorial policy checks and supported editorial team): Leticia Rodrigues, Central Editorial Service. Copy Editor (copy-editing and production): Jessica Sharp. Peer-reviewers (provided comments and recommended an editorial decision): Dominic Thyagarajan, MD, FRACP, Monash University, Melbourne, Australia (clinical review); Adam Vogel, The University of Melbourne, Australia (clinical review); Robin Featherstone, Cochrane Central Editorial Service (search review); Nuala Livingstone, Cochrane Evidence Production and Methods Directorate (methods review).